Depomed’s Gabapentin GR Fails Phase III Postherpetic Neuralgia Study

Outcome is not expected to affect product’s ongoing clinical development for menopausal hot flashes.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet